Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation
Status:
Unknown status
Trial end date:
2020-04-01
Target enrollment:
Participant gender:
Summary
This is a study of HMB plus amino acids in older men with prostate cancer starting androgen
deprivation therapy (ADT). The investigators hypothesize that the use of this nutritional
supplementation will decrease the loss of muscle mass and strength that occurs when men start
ADT.